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Abstract
Background: Emx2 encodes for a transcription factor expressed in the embryonic intermediate mesoderm and central
nervous system (CNS). It is implicated in several aspects of cerebral cortex development, including morphogenetic field
specification, arealization, precursor proliferation and lamination. Four Emx2-associated antisense transcripts have been
found in the urogenital system; one of them, Emx2OS, has been also detected in the adult brain. Until now, however,
nothing is known about expression and function of Emx2OS in the developing CNS.
Methodology/Principal Findings: By quantitative RT-PCR and in situ hybridization, we reconstructed the Emx2OS
expression profile in the embryonic CNS, paying special attention to the developing cerebral cortex. Emx2OS was observed
in a number of CNS structures expressing also Emx2. Within the cortex, Emx2OS was detectable in periventricular precursors,
expressing the sense transcript, and peaked in newly born post-mitotic neurons not expressing such transcript. By
integrating lentiviral gene delivery, RNAi, TetON technology, morpholino-mediated gene knock-down, drug-induced
perturbation of gene expression, and quantitative RT-PCR, we addressed possible roles of Ex2 antisense RNA in Emx2
regulation, in primary CNS precursor cultures. We found that, in both cortical precursors and their neuronal progenies, Emx2
antisense RNA contributes to post-transcriptional down-regulation of its sense partner, possibly by a Dicer-promoted
mechanism. The same RNA, when delivered to rhombo-spinal precursors, stimulates ectopic expression of Emx2, whereas
Emx2 knock-out dramatically impairs Emx2OS transcription. This suggests that, within the developing CNS, a reciprocal
Emx2/Emx2OS regulatory loop may normally sustain transcription at the Emx2 locus.
Conclusions/Significance: This study shows that antisense transcripts may contribute to developmental regulation of a key
transcription factor gene implicated in CNS patterning, possibly by complex and multilevel mechanisms. The activation of
Emx2 by a short antisense transcript may be a prototype of a method for overexpressing single specific genes, without
introducing additional copies of them into the genome.
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Introduction
Emx2 is a transcription factor gene expressed in the developing
urogenital and central nervous systems (CNS) [1,3], crucial for
proper morphogenesis of these structures [4,6]. It is implicated in
dorso-ventral specification of the rostral neural tube, conferring
cortico-cerebral identity to precursors in the dorsal telencephalic
vesicle and repressing the activation of striatal morphogenetic
programs [7]. Expressed by cortical periventricular precursors
along a caudal/medialhigh-to-rostral/laterallow gradient, it further
promotes the specification of hippocampus and occipital cortex,
while antagonizing rostral-lateral areal programs [8–10]. Within
the embryonic brain, it stimulates neural precursors’ self-renewal,
at expenses of neuronal differentiation; these effects are apparently
reverted in post-natal neural stem cells [11–14]. Finally, Emx2 is
crucial to proper inside-out layering of the neocortical primordi-
um. In its absence, pioneer Cajal-Retzius cells orchestrating such
process are severely reduced and the neocortical lamination profile
is deeply distorted, in a reeler-like way [15,16].
Four main Emx2 antisense transcripts of 6.0, 5.0, 2,3 and 1,8 kb
have been detected in the murine urogenital system by Northern
blotting and a cDNA corresponding to the second of them,
Emx2OS, has been isolated. Emx2OS expression has been studied
by in situ hybridisation in the uro-genital system: like Emx2-mRNA,
Emx2OS-ncRNA is abundant in normal postmenopausal endo-
metrium, reduced in premenopausal endometrium, absent/
reduced in many primary endometrial tumors [17]. Moreover,
its human counterpart has been specifically detected in the adult
brain, by Northern blot [17]. However, the Emx2OS expression
profile has not been studied in the developing CNS and little is
known about possible implication of Emx2OS in fine regulation of
Emx2.
Several transcription factor genes implicated in CNS develop-
ment harbor antisense transcripts. Antisense transcripts are
encoded by Six3 [18], Msx1 [19–23], Pax6, Pax2, Six3, Six6,
Otx2, Crx, Rax, Vax2 [24], Dlx 5/6 [25] and Hox loci [26–28]. More
generally, antisense transcription is a genome-wide phenomenon,
estimated to be associated with at least 10–40% of polypeptide-
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encoding genes [29–38]. Antisense/Sense (AS/S) pairs may be
structurally classified as divergent, overlapping and convergent
and it has been shown that they may display concordant,
discordant or more complex expression patterns [39].
Based on various relationships occurring among AS expression
levels and those of their sense partners, it has been predicted that
the former ones might differentially promote or antagonize the
expression of such partners, depending on the gene and on the
context. Such prediction has been substantially confirmed in a
variety of functional studies, indicating that: (1) AS transcription is
not simple transcriptional noise or epiphenomenon of S transcrip-
tion [36], but often results a prerequisite for proper regulation of
‘‘coding’’ sense genes; (2) molecular mechanisms by which AS
transcripts act are extremely complex and largely diversified
[39,40].
In some cases, poor sequence conservation but similar exon/
intron organisation characterizing antisense transcripts from
different species suggests that transcription per se, and not the AS
RNA molecule, may be crucial to the function. That has been
demonstrated in the case of the silent human provirus HERV-
K18, where AS transcription promotes S transcription [41], as
well as in a variety of other cases, where AS transcription
conversely inhibits S transcription, because of competition
between the two transcriptional machineries for shared cofactors,
or due to collision between them [42].
However, the AS transcript may also work as such, acting at
distinctive regulatory levels. First, it may regulate the epigenetic
state of chromatine, modulating the methylation state of DNA
and/or histones [27,43,44]. Second, it may facilitate recruitment
of transcription factors to enhancers impinging on the partner
sense gene, so promoting its transcription. This is the case of the
Evf2 ncRNA, cooperating with the homeoprotein Dlx2 in
stimulating transcription of its sense partner Dlx6 [25]. Third,
the AS ncRNA may modulate the splicing of its partner sense pre-
mRNA, as reported for the TRa2 and Zeb2 loci [45,46]. Fourth,
AS transcripts may regulate the half-life of their sense partners.
Pairing of retrotransposon sense and antisense transcripts paves
the way to Dicer-dependent cutting of resulting dsRNAs, followed
by siRNA-instructed silencing of sense transcripts, from the same
or paralogous loci [47–49]. Fifth, antisense RNAs may modulate
translation [50]. Last, they may be necessary for proper activity of
their sense partners, as shown for the Xist/Tsix pair [51].
In this study, we investigated the expression pattern of Emx2OS-
ncRNA in the developing CNS, by quantitative reverse transcrip-
tion polymerase chain reaction (qRT-PCR) and in situ hybridisa-
tion (ISH). Then, by integrating lentiviral cDNA delivery, drug-
induced perturbation of patterning pathways and gain- or loss-of-
function (GOF and LOF, respectively) designs, we addressed
possible roles of this transcript on regulation of its partner gene,
Emx2, on primary CNS cultures as well as on cell lines. We found
that Emx2 antisense transcripts may both stimulate and refine
Emx2 expression. Moreover, such effects seem to be exerted at two
distinct regulatory levels, transcriptional and post-transcriptional.
These results, beyond their contribution to the comprehension
of mechanisms regulating cortico-cerebral development, suggest a
possible general exploitation of AS-based methods, as a tool for
artificial triggering of endogenous gene expression.
Results
Expression Pattern of Emx2OS-ncRNA
To get a first insight into expression and putative functions of
Emx2OS-ncRNA, we compared its abundance with that of Emx2-
mRNA, in cortico-cerebral and rhomboencephalic tissues, at four
embryonic developmental ages, E10.5, E12.5, E14.5 and E18.5.
As expected, Emx2-mRNA was specifically detectable in the
cortex, where its levels went progressively down from E10.5 up to
E18.5 [3,52]. Interestingly, Emx2OS-ncRNA displayed similar
spatial specificity and similar temporal progression (Fig. 1A and 2).
Then, we studied the Emx2OS-ncRNA expression pattern in the
developing central nervous system (CNS), by non-radioactive in situ
hybridisation (Fig. 1A). At E12.5, within the CNS, the transcript was
detectable in the telencephalon (Fig. 3A,B), including both pallium
and basal ganglia (Fig. 4A), in the mammillary recess of the
hypothalamus (Fig. 3A, arrowhead) and in the midbrain, including
tectum and tegmentum (Fig. 3C). No signal was detectable within
the rhombo-spinal domain (Fig. 3A,D). Emx2OS was also expressed
by the nasal pits (Fig. 3E), the otic vesicle (Fig. 3G), the choroid
plexus of II and IV ventricle (Fig. 3A,D), as well as by two clusters of
head mesenchyme cells, in the snout region (Fig. 3A, asterisk) and
in the surroundings of the hypothalamic optic recess (Fig. 3F,
arrowheads).
Focussing our attention on the developing cerebral cortex, we
found Emx2OS transcripts within periventricular proliferative
layers, from E12.5 to E18.5 (Fig. 4A–F), as well as in the cortical
plate (CP), especially in its more superficial part (Fig. 4E,F).
Conversely, no signal was detectable within the preplate (PPL) and
its derivatives, marginal zone (MZ) and subplate (SP) (Fig. 4D–F).
In particular, no Emx2OS transcripts could be found within Cajal-
Retzius (CR) cells, aligned beneath the pia mater and specifically
expressing Reln mRNA, in both neocortex and hippocampus
(Fig. 4G–L, empty and solid arrowheads).
Emx2OS Antagonizes Emx2 Expression
The mutually exclusive distribution of Emx2-mRNA and
Emx2OS-ncRNA among cortico-cerebral neurons (the former
expressed by CR neurons, the latter by CP neurons) suggested to
us that reciprocal down-regulation between them might occur and
that, in particular, Emx2OS-ncRNA might be implicated in
repression of Emx2mRNA.
We first assayed this hypothesis by a LOF approach, i.e., by
knocking-down Emx2OS-ncRNA in primary neurospheres derived
from E12.5 cortical tissue, via RNAi, and monitoring consequenc-
es of that on Emx2-mRNA levels. For this purpose, we used a
lentivirus constitutively expressing miR-aEmx2OS-774 (Fig. 1B),
an artificial miR able to target Emx2OS sequences in HeLa cells
(Fig. 5A). Under miR-aEmx2OS-774, Emx2OS-ncRNA signal was
reduced by more than 2 times (p,0.002; n = 9) (Fig. 5B, left).
Concomitantly, we observed a modest (+25%), but statistically
significant (p,0.03; n = 9) increase of Emx2-mRNA.
To assess if upregulation of Emx2 induced by miR-aEmx2OS-
774 took place at transcriptional or post-transcriptional level, we
then measured Emx2 pre-mRNA levels, following infection of
neurospheres with miR-aEmx2OS-774 or negative control lenti-
viruses. For sake of sensitivity and specificity, measurements were
done by two-step quantitative RT-PCR, using two sets of nested
primers annealing within the first Emx2 intron (Fig. 1A).
Interestingly, no change in Emx2 pre-mRNA levels was found
(Fig. 5B, right), suggesting that Emx2OS-dependent regulation of
Emx2 took place at post-transcriptional level.
Remarkably, in previous sets of experiments, neural cultures
were performed in DMEM/F12/N2 medium, containing the
standard growth factors (GFs) mix which promotes the intermi-
totic/stem state [53]. As during embryonic development Emx2-
mRNA disappears in post-mitotic neurons, where Emx2OS-
ncRNA is transiently upregulated, the question arises: is Emx2OS-
ncRNA able to down-regulate Emx2-mRNA also in nascent
neurons? To address this issue, the Emx2OS-LOF tests were
Emx2OS in Cerebral Precursors
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Figure 1. Synopsis of molecular tools used for studying expression and function of Emx2OS. (A) Representation of the murine Emx2 locus,
with the Emx2-mRNA and the Emx2OS-ncRNA transcription units (red). Genomic localization of the riboprobe used for in situ hybridization analysis of
Emx2OS (blue bar). Genomic localization of the oligonucleotides employed for quantitative RT-PCR evaluation of Emx2OS-ncRNA (P1 and P3), Emx2-
mRNA (N2F and N2R) and Emx2-pre-mRNA (I1, I2, I3 and I4) (blue arrowheads). (B) Structure of the bi-cistronic plasmids employed for assaying
activities of artificial miRNAs against Emx2OS-ncRNA in HeLa cells and of lentivectors for overexpressing these miRNAs in primary cells. Localization of
miR-aEmx2OS-542 and -774 (blue arrowheads) as well as of their responsive element, miR-RE, with respect to the antisense transcript. miR-RE (dark
yellow), showed enlarged over the antisense transcript, extends across the 3rd and the 4th exons of it. (C) Structure of the ‘‘driver’’ lentivector, guiding
constitutive expression of rtTA2S-M2, and of ‘‘expressor’’ lentivectors, guiding rtTA/doxycycline-dependent expression of ncRNA/IRES/eGFPcds
modules. Genomic localization of OS1-179(+) and OS1-179(2) ncRNAs (blue arrows), as compared to Emx2OS-ncRNA and Emx2-mRNA (for sake of
clarity, the sense/antisense ovarlapping region and its surroundings are represented enlarged; red, non coding sequences; violet, coding sequences).
doi:10.1371/journal.pone.0008658.g001
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repeated culturing the infected cells in the presence of 5% serum,
which stimulates neuronal differentiation, in place of GFs.
Moreover, in this new experiment an aliquot of miR-C-infected
cells was kept under GFs, as a control. Consistently with our
expectations, under 5% serum plus miR-C lentivirus, neuronal
differentiation was dramatically stimulated, as confirmed by
massive activation of neuron-specific b-tubulin (Fig. 5C, top),
Emx2-mRNA level decreased, by about 30% (Fig. 5C, bottom-
right), and Emx2OS-ncRNA was only slightly downregulated
(Fig. 5C, bottom-left). Remarkably, knock-down of Emx2OS
induced by miR-aEmx2OS-774 rescued the Emx2-mRNA de-
crease to large extent (Fig. 5C, bottom-right), suggesting that
Figure 3. Distribution of Emx2OS transcripts in the embryonic
E12.5 mouse brain. (A–D) Within the E12.5 developing CNS, Emx2OS-
ncRNA is detectable in telencephalon (A,B), mesencephalon (me),
including both tectum (te) and tegmentum (tg), (panels A,C) and
diencephalon, including the mammillary recess (arrowhead in panel A).
It is not present in rhombencephalon (rh, panel G), except the choroid
plexus of the IV ventricle (chp, panels A,D). Outside the CNS, Emx2OS is
expressed in primordia of sense organs, nasal pits (np, panel E) and otic
vesicle (ov, panel G), as well as in mesenchyme underlying snout
epidermis (A, asterisk) and surrounding the hypothalamic (hy) optic
recess (F, arrowheads). Scalebars, 200 mm in A–C, 50 mm in D–G.
doi:10.1371/journal.pone.0008658.g003
Figure 4. In situ hybridization profile of Emx2OS-ncRNA in the
developing mouse telencephalon. Distribution of Emx2OS-ncRNA
(A–I) and Reln-mRNA (J–L) on mid-frontal sections of E12.5 (A), E14.5 (B)
and E18.5 (C,G,J) mouse telencephalons. (D), (E) and (F) are
magnifications of boxed areas in (A), (B) and (C), respectively. (H) and
(I) are enlargements of boxed areas of panel (G), respectively; the same
applies to panels (K) and (L) with respect to (J); (G) and (J) are adjacent
sections from the same brain. Emx2OS is expressed in periventricular
proliferative layers at all ages subject of analysis (A–C). An additional
signal is detectable within the cortical plate starting from E14.5 (B) and
gets confined to its marginal-most part at E18.5 (C). No Emx2OS
expression can be detected in the neocortical marginal zone (G,H,
empty arrowheads) as well as in the archicortical stratum lacunosum-
moleculare (G,I), both rich of Reln+ Cajal-Retzius cells (J–L, solid
arrowheads). Some aspecific staining may be found in meninges, at
the edge of sections. Abbreviations: CA1, cornu Ammonis field 1; CA3,
cornu Ammonis field 3; cp, CP, cortical plate; DG, dentate gyrus; HF,
hippocampal fissure; iz, intermediate zone; mz, MZ, marginal zone; ppl,
preplate; SLM, stratum lacunosum-moleculare; sp, subplate; svz,
subventricular zone; vz, ventricular zone; Scalebars, 200 mm.
doi:10.1371/journal.pone.0008658.g004
Figure 2. Time-course quantitative RT-PCR analysis of Emx2-
mRNA and Emx2OS-ncRNA expression in the developing cortex
and rhombencephalon. Sense and antisense transcripts display
concordant spatial distributions (abundant in the cortex, absent in
rhombencephalon), from E10.5 to E18.5. Within the cortex, they share a
similar temporal trend, being progressively down-regulated from the
pre-neuronogenic (E10.5) to post-neuronogenic stages (E18.5). RTs are
primed by random hexamers and PCRs by oligos shown in Fig. 1. Data
are normalized on E10.5 cortical samples. Abbreviations: c, cortex; r,
rhombencephalon.
doi:10.1371/journal.pone.0008658.g002
Emx2OS in Cerebral Precursors
PLoS ONE | www.plosone.org 4 January 2010 | Volume 5 | Issue 1 | e8658
Figure 5. Emx2OS knock-down in HeLa cells and dissociated cortico-cerebral precursors. (A) Down-regulation of the miR-RE-sensitized
DsRed2 reporter in Hela cells, upon overexpression of artificial miRNAs designed against Emx2OS. (B) Down-regulation of Emx2OS-ncRNA, up-
regulation of mature Emx2-mRNA and unchanged levels of immature Emx2-pre-mRNA in E12.5-derived cortical primary cells (cx), acutely infected by
miR-aEmx2OS-774-expressor lentivirus, kept in Sato medium and harvested 72 hours later. Data are normalized on control-miR-treated samples (miR-
C). (C) Neuronal differentiation of lentivirus-transduced neural precursors kept 72 hours under 5% serum, as assessed by b-tubulin immunoprofiling.
Down-regulation of Emx2-mRNA in miR-C-infected neural precursors, kept 72 hours under 5% serum in place of growth factors (GFs). Rescue of such
down-regulation, elicited via miR-aEmx2OS-774-induced knock-down of Emx2OS-ncRNA. qRT-PCR data are normalized on control-miR-treated
samples (miR-C), kept under GFs.
doi:10.1371/journal.pone.0008658.g005
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Emx2OS-ncRNA substantially contributes to Emx2 down-regula-
tion at the time when CP neurons are born.
Then, to confirm this model, we verified it by a complementary
GOF approach, i.e. by delivering antisense Emx2 cDNA to
embryo-derived neurospheres, via lentiviral vectors, and scoring
consequences of that.
Unfortunately, the full-length 5.0 kb Emx2OS cDNA harbors
several canonical polyadenylation signals, which make it hardly
suitable for our lentiviral expression system. So, in place of it, we
overexpressed its 59-most 179 bp fragment, coinciding with the
Emx2-mRNA/Emx2OS-ncRNA overlapping region minus a low-
complexity 74 bp polypyrimidine tract. Assuming - in fact - that
Emx2OS-ncRNA works by interacting with Emx2-mRNA via
Watson&Crick base-pairing, this short fragment could recapitulate
key regulative properties of the full-length Emx2OS-ncRNA.
Moreover, in order to assay both consequences of antisense
overexpression and their reversibility, we performed Emx2OS-
GOF manipulations by a dual, TetON-based, lentiviral delivery
system, triggered by doxycycline. Neurospheres were infected by a
‘‘driver virus’’, harboring a constitutively expressed rtTA2S-M2
transactivator gene, plus an ‘‘expressor virus’’, harboring the
cDNA sequence subject of investigation (Fig. 1C).
Compared to the control, the Emx2 antisense-encoding
lentivirus OS1-179(+) reduced the Emx2-mRNA level by 24.2%
(p,0.001). OS1-179(2), encoding for the corresponding reverse-
complementary sequence, increased it by 34.2% (while not
reaching statistical significance). Moreover, Emx2-mRNA levels
under OS1-179(+) and OS1-179(2) differred by 243.7%
(p,0.01). Remarkably, these changes of Emx2-mRNA levels were
mirrored by opposite concomitant changes of Emx2OS-ncRNA
(Fig. 6A). In synthesis, OS1-179(+) both down-regulates Emx2-
mRNA and promotes the expression of the endogenous antisense
transcript, which may in turn contribute to Emx2 down-regulation.
As for molecular mechanisms mediating Emx2OS-dependent
Emx2-mRNA down-regulation, we hypothesized that the antisense
ncRNA might destabilize the sense mRNA, forming a double
strand with it and so preparing its degradation by double-strand
ribonucleases. Among these enzymes, a reasonable candidate
might be Dicer1, involved in dsRNA-mediated destabilization of
retrotransposon transcripts [47-49] and crucial to generation and
survival of cortico-cerebral neurons [54]. To test this hypothesis,
we decided to repeat the GOF experiments described above in
cells alternatively provided with Dicer1 activity or deprived of
it, by morpholino technology [55,56]. To get the best Dicer1
knock-down, NIH/3T3 cells, among the easiest to transfect by
established morpholino reagents, were selected as a substrate.
Combined Dicer1-knock-down (DicerKD) by a-Dicer1 mor-
pholino and OS1-179(+)/OS1-179(-)-GOF manipulations were
performed, according to the schedule in Fig. 6B. Results were as
follows. Lentivirus OS1-179(+) downregulated Emx2-mRNA in all
tested conditions. Compared with lentivirus-C treated controls,
relative levels of Emx2-mRNA upon OS1-179(+) infection, changed
by a factor of 0.56/1 = 0.56 (p,0.001) - and 1.42/1.65 = 0.87
(p,0.01), in wild type and Dicer1-KD NIH/3T3 cells, respec-
tively. Morpholino a-Dicer1 gave conversely rise to a robust
increase of Emx2-mRNA. Compared with morpholino-C-treated
controls, relative levels of Emx2-mRNA under a-Dicer1 changed
by a factor of 1.42/0.56 = 2.54 (p,0.001), 1.65/1 = 1.65
(p,0.001), and 1.82/1.31 = 1.39 (p,0.01), in cells infected by
OS1-179(+), control or OS1-179(2) lentiviruses, respectively.
The stronger effect elicited by OS1-179(+) in the presence of
normal levels of Dicer1 and the more pronounced effect elicited
by a-Dicer1 when associated to OS1-179(+) suggested that a specific
functional interaction could occur between Dicer1 and the antisense
transcript. Remarkably, two-ways ANOVA re-analysis of Emx2
expression data confirmed this suspect, with p,0.025 (Fig. 6B).
Summarizing: (1) Emx2-mRNA is normally down-regulated by
Dicer1; (2) the antisense RNA fragment overlapping Emx2-mRNA
destabilizes it; (3) Dicer1 promotes such antisense-dependent
mRNA destabilization.
Emx2OS Transcripts Promote Both Emx2-mRNA and
Emx2OS-ncRNA Expression
The specific co-expression of Emx2OS-ncRNA and Emx2-mRNA
by neural precursors belonging to defined regions of the developing
CNS suggested that antisense transcripts, in addition to trigger
destabilization of Emx2-mRNA, might be also basically implicated in
promoting its transcription. This hypothesis was tested by over-
expressing Emx2 antisense sequences in neural precursors from the
rhombo-spinal tract, a CNS segment which normally does not
express Emx2 [1,2] (Fig. 1C). As basal expression levels of Emx2 in
rhombo-spinal precursors are very low (near the experimental
background) and this might make it difficult to estimate the relative
change of transcript level elicited by OS1-179(+), the following
device was adopted. The experiment was alternatively run under
standard neurosphere medium [15], or upon addition of a specific
lithium/cyclopamine drug mix, which, stabilizing the transcription
factor (TF) beta-catenin [57] and preventing inhibition of the TF
Gli3 [58], promotes Emx2 transcription [59–61], so as to increase the
baseline of the assay and ameliorate its signal-to-noise ratio (Fig. 7A).
As expected, the Emx2 expression level in rhombo-spinal cells,
infected with control virus and kept in the absence of drugs, resulted
far lower than in telencephalic cells exposed to lithium/cyclopa-
mine. The Emx2 level slightly rose, upon treatment of rhombo-
spinal cells by either the OS1-179(+) virus or the lithium/
cyclopamine mix (about 2 and 4 times, with p,0.01 and
p,0.001, respectively). Interestingly, simultaneous exposure of
rhombo-spinal cells to both OS1-179(+) virus and lithium/
cyclopamine elicited a much more dramatic up-regulation effect
(almost 30 times, with p%0.001), so confirming the effectiveness of
the OS1-179(+) virus and further suggesting a powerful synergy
between such virus and the drug cocktail (p,0.001) (Fig. 7A, upper
histograms). In other words, as hypothesized, Emx2OS transcripts
may activate Emx2 expression and the amplitude of this phenom-
enon is much more prominent, upon appropriate pharmacological
modulation of the nuclear TF milieu impinging on Emx2 regulation
[57,59]. Noticeably, changes of Emx2-mRNA levels elicited by
pharmacological and genetic manipulations described above were
paralleled by strikingly similar changes of Emx2OS-ncRNA (Fig. 7A,
lower histograms). This indicates that both reasonably originated
from concerted stimulation of sense and antisense transcription at
the Emx2 locus. This also suggests that the upregulation of Emx2-
mRNA triggered by artificial OS1-179(+) administration might be
further sustained by endogenous antisense transcripts from the same
locus, induced by OS1-179(+) itself (Fig. 7A).
As the previous experiment was done by keeping the OS1-179(+)
transgene chronically on, it was poorly informative about the
kinetics and, in particular, the reversibility of the Emx2 activation
triggered by antisense transcripts. To address this issue, we repeated
the OS1-179(+) overexpression test over 120 hours, limiting neural
precursors exposure to doxycycline to the first 72 hours (Fig. 7B).
Results of this test were as follows. Withdrawal of doxycycline
at 72 hours allowed full shutting off of OS1-179(+)-ncRNA
at 120 hours, as witnessed by the absence of associated eGFP
fluorescence (Fig. 7B, panels to the top). Remarkably, this was
accompanied by a collapse of endogenous Emx2 sense and
antisense transcripts to levels peculiar to rhombo-spinal cells
infected by the control virus (Fig. 7B, histograms).
Emx2OS in Cerebral Precursors
PLoS ONE | www.plosone.org 6 January 2010 | Volume 5 | Issue 1 | e8658
In other words, even low, but persisting levels of antisense
transcripts seem to be sufficient and strictly necessary for proper firing
of the Emx2 transcription unit. This might explain why Emx2 sense
and antisense transcripts have normally to be co-expressed in
proliferative layers of the early developing CNS.
Absence of Emx2 Sense Transcription and/or Its Products
Impairs Emx2OS-ncRNA Expression
The association between Emx2OS and Emx2 transcripts might
also imply a reciprocal, complementary dependence of Emx2OS-
ncRNA expression on Emx2 sense transcription. To address this
issue, we compared levels of Emx2OS transcripts in E12.5 cortices
from Emx2+/+, Emx2+/2 and Emx22/2 mouse embryos [4]. The
Emx2 null allele of these mutants - in fact - lacks only a 250bp
genomic fragment encoding for the C-term of the homeodomain
(not provided of any known cis-regulatory activities), has an intact
divergent-promoter region and still harbors the two main
enhancers which drive transcription in the developing telenceph-
alon [4,57]. As such, it should in principle be able to normally
drive the synthesis of its antisense transcript.
Notwithstanding that, we found that Emx2OS-ncRNA was
down-regulated by more than 80% in homozygous null mutants
Figure 6. Emx2 and Emx2OS expression in dissociated cortico-cerebral precursors and NIH/3T3 cells upon OS1-179(+) delivery. (A)
Emx2-mRNA and Emx2OS-ncRNA expression in primary neural precursor cells, derived from E12.5 cortices (cx) and acutely infected with the ‘‘driver’’
lentivector, plus ‘‘expressor’’ lentivectors [OS1-179(+), OS1-179(–) and control (C)] in different combinations. One day after sample dissociation, cells
are administered with doxycycline and, two more days later, profiled for RNA. Data are normalized on control lentivirus-treated samples. OS1-179(+)
induces a moderate, but statistically significant down-regulation of Emx2-mRNA, as well as a moderate up-regulation of the endogenous antisense
transcript. (B) Emx2-mRNA expression in NIH/3T3 cells, acutely infected with the ‘‘driver’’ lentivector plus each of the three ‘‘expressor’’ lentivectors
[OS1-179(+), OS1-179(-) or C]. Cells are administered 6 hours after infection with an anti-Dicer1 or a control (C) morpholino and 18 more hours later
with doxycycline. Two more days later, they are RNA-profiled by qRT-PCR. Data reported in the histogram are normalized on samples infected by
control lentivirus and exposed to control morpholino. Compared with lentivirus-C-treated controls, levels of Emx2-mRNA change upon OS1-179(+)
infection by a factor of 0.56/1 = 0.56 (p,0.001) and 1.42/1.65 = 0.87 (p,0.01), in NIH/3T3 cells treated by control morpholino and a-Dicer1,
respectively. Compared with morpholino-C-treated controls, levels of Emx2-mRNA change upon a-Dicer1 administration by a factor of 1.42/
0.56 = 2.54 (p,0.001), 1.65/1 = 1.65 (p,0.001), and 1.82/1.31 = 1.39 (p,0.01), in cells infected by OS1-179(+), control or OS1-179(–) lentiviruses,
respectively. Two-ways ANOVA data analysis suggests the occurrence of a functional interaction between Dicer1 and OS1-179(+), with p,0.025
(Fig. 6B).
doi:10.1371/journal.pone.0008658.g006
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Figure 7. Ectopic activation of Emx2-mRNA and Emx2OS-ncRNA in rhombo-spinal neurospheres, upon OS1-179(+) delivery. (A)
Ectopic activation of the endogenous Emx2 locus by OS1-179(+). The two graphs show Emx2-mRNA and Emx2OS-ncRNA expression levels in primary
neural precursors from distinctive portions of the E10.5 CNS, rhombo-spinal tract (rh/sc) and telencephalon (te), acutely infected with ‘‘driver’’ and
‘‘expressor’’ lentivectors (Fig. 1C), kept under doxycycline and added or not with the Li+/cyclopamine mix. Samples are RNA-profiled 72 hours after
infection. Data are normalized on telencephalic precursors exposed to Li+/cyclopamine, infected by control lentivirus and kept under doxycycline.
Basal Emx2 expression by rhombo-spinal cells, very low as compared to telencephalic precursors, rises about 2 (p,0.01), 4 (p,0.001) and 30 times
(p,0.001), upon treatment of these cells with the OS1-179(+) virus, the drug mix, or both, respectively. Two-ways ANOVA indicates that a specific
interaction between OS1-179(+) and the drug mix takes place, with p,0.001. A similar course is shown by Emx2OS-ncRNA. (B) Reversibility of OS1-
179(+)-dependent activation of the endogenous Emx2 transcription unit. The four panels to the top show time course analysis of eGFP fluorescence
in neural precursors, infected by driver and OS1-179(+) lentiviruses and kept under doxycycline for 72 or 120 hours. The absence of fluorescence in
the bottom-right panel means that withdrawal of doxycycline at 72 hours is sufficient to reset levels of the eGFP/OS1-179(+) chimaeric transcript to
zero by 120 hours. The two graphs to the bottom show Emx2-mRNA and Emx2OS-ncRNA expression levels in primary neural precursors from the
E10.5 rhombo-spinal (rh/sc) tract, acutely infected with ‘‘driver’’ and ‘‘expressor’’ lentivectors (Fig. 1C), kept under doxycycline for 72 or 120 hours and
chronically exposed to Li+/cyclopamine throughout the experiment. Samples are RNA-profiled 120 hours after infection. Data are normalized on
rhombo-spinal cells exposed to Li+/cyclopamine, infected by OS1-179(+) lentivirus and kept under doxycycline throughout the experiment. Removal
of doxycycline at 72 hours abolishes (p,0.01) the 4-fold up-regulation of Emx2-mRNA, detectable in Li/cyclopamine-treated rhombo-spinal
precursors, upon their further infection by lentivirus OS1-179(+) (p,0.01). Similar consequences are elicited by doxycycline removal on levels of
Emx2OS-ncRNA.
doi:10.1371/journal.pone.0008658.g007
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and by 50% in heterozygous mutants (Fig. 8), suggesting that - as
suspected - Emx2 sense transcription and/or its products are in
turn necessary for proper expression of Emx2OS-ncRNA.
Discussion
In this study we investigated the expression pattern of Emx2OS-
ncRNA, the antisense transcript associated to the transcription
factor gene Emx2, in the developing mouse CNS. Then, we
preliminarly addressed its involvement in regulation of Emx2
expression.
As shown by qRT-PCR (Fig. 2) and in situ hybridisation (Fig. 3),
Emx2OS is specifically expressed by a number of CNS substruc-
tures and sense organs also expressing Emx2. Among them:
telencephalon, mammillary recess, optic tectum, olfactory placode,
otic vesicle [1,3]. Such colocalization of the two transcripts in
periventricular layers of defined neural tube domains recalls the
identical expression patterns they display in the uterine endome-
trium [17]. Emx2/Emx2OS colocalization might be an epiphe-
nomenon of shared regulatory mechanisms impinging on both.
Alternatively, transcription of one or both units might specifically
promote the other and, in particular, antisense transcription might
contribute to specifically keep Emx2 on in neural precursors of
defined spatial domains.
Remarkably, the two transcripts, both expressed by periven-
tricular neural precursors of the cortical primordium, display a
mutually exclusive pattern in post-mitotic progenies of such
precursors. Newborn neurons belonging to the cortical plate
strongly express Emx2OS-ncRNA, expecially at the end of their
radial migration (Fig. 4E,F), but not Emx2-mRNA (while still
harboring residual Emx2 immunoreactivity) [1-3]. Pioneer Cajal-
Retzius neurons lying in the marginal zone conversely express
huge amounts of Emx2 mRNA and protein [3], but no antisense
transcript at all (Fig. 4G,L). Such mutual distribution recalls the
complementary expression patterns displayed by Otx2/Otx2OS
and Crx/CrxOS pairs in the adult retina, with the sense
transcription factor genes expressed predominantly in photore-
ceptors and the corresponding OS genes in bipolar interneurons
and ganglionic projection neurons [24]. The mutual distribution of
Emx2 and Emx2OS RNA products points to a possible negative
cross-regulation between them and, in particular, to an involve-
ment of the former in fine control of post-mitotic silencing of the
latter.
As for the biological meaning of Emx2/Emx2OS co-expression,
we tested the hypothesis that sense and antisense transcription
from the Emx2 locus might reciprocally sustain each other.
To assay if Emx2OS-ncRNA is able to promote Emx2-mRNA
expression, a 59 fragment of the former was overexpressed in
rhombo-spinal precursors, normally expressing none of them. As
suspected, delivery of this fragment, OS1-179(+)-ncRNA, into
such cells elicits strong Emx2 upregulation. No direct assessment of
the level, transcriptional or post-transcriptional, at which this
phenomenon takes place, was performed. However two consider-
ations suggests that the former possibility may hold good. First,
OS1-179(+) synergizes with a drug mix specifically up-regulating
beta-catenin, a key trans-activator binding the two telencephalic
enhancers of Emx2 [59]. Second, up-regulation of Emx2 is
faithfully paralleled by Emx2OS up-regulation.
Concerning mechanisms mediating transactivating properties of
OS1-179(+) (as well of Emx2OS-ncRNA), two hypotheses may be
taken into accont. Both molecules might interact with transcrip-
tion factors impinging on the Emx2 locus, ameliorating their
binding to the chromatin and/or their processivity (like the Evf2-
ncRNA at the Dlx5/6 locus) [25]. Alternatively, antisense
transcripts or their by-products might make the epigenetic state
of Emx2 chromatine more permissive to gene expression, by
recruiting appropriate modifier enzymes to it. However, modifier
enzymes recruited by antisense RNAs, rather than facilitating gene
expression, often make chromatine less prone to transcription
[27,43,44]. Consistent with these considerations, the need of
persistent OS1-179(+) expression to get Emx2 activation and the
capability of the only drug cocktail to elicit weak but reproducible
Emx2 upregulation induce us to rule out the latter hypothesis and
to consider the former more likely. Beyond mechanics of OS1-
179(+) action, such activation of Emx2 by a short antisense
transcript is nonetheless remarkable, as possible prototype of a
general method for overexpressing single specific genes, without any
need to introduce additional copies of them into the genome,
similarly to classical RNAa [62–65].
To ascertain if Emx2OS-ncRNA expression reciprocally depends
on Emx2 transcription (and/or its products), Emx2OS levels were
scored in Emx2 mutant mice, not harboring any gene lesions
obviously incompatible with Emx2OS transcription. Remarkably,
in such mice, both Emx2 and Emx2OS transcripts are dramatically
down-regulated, echoing the collapse of Vax2OS (Vax2 opposite
strand) occurring in mice knock-out for the cognate transcription
factor gene Vax2 [24]. Multiple are mechanisms possibly
underlying such down-regulation. Among the most likely ones,
the depression of the Emx2/Wnt mutually-sustaining loop [9,59],
leading to a decrease of the nuclear beta-catenin pool which
normally stimulates transcription at the Emx2 locus [59]. Such
mechanisms - however - were not addressed at all in this study;
they will be subject of a further dedicated one.
So, based on Emx2OS down-regulation in Emx2-null mutants as
well as on consequences of OS1-179(+) overexpression in rhombo-
spinal precursors, we can speculate now that mutual promotion of
sense and antisense transcription at the Emx2 locus may be a
crucial pre-requisite for proper activation and expression of Emx2.
Maybe that is why Emx2 sense and antisense transcripts have to be
co-expressed in defined domains of the early neural tube.
We also tested whether Emx2OS is also implicated in
downregulation of Emx2, by artificially modulating Emx2 antisense
levels in cortico-cerebral neural precursors. An inverse correlation
was found between levels of Emx2OS and Emx2 transcripts,
Figure 8. Down-regulation of Emx2-mRNA and Emx2OS-ncRNA in
acutely dissected cortices from E12.5 Emx2 null mutant embry-
os. Abbreviations: wt, wild type; he, heterozygous; ko, knock-out.
doi:10.1371/journal.pone.0008658.g008
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confirming that the former may normally contribute to down-
regulation of the latter. Changes of Emx2-mRNA levels elicited by
Emx2OS-RNAi are not reflected by the course of the correspond-
ing pre-mRNA, that remains stable as found by intronic qRT-
PCR. This further indicates that Emx2OS-dependent modulation
of Emx2 takes place post-transcriptionally. Antisense-promoted
down-regulation of Emx2 is weakened by Dicer1 knock-down,
suggesting that Dicer1 might promote such process by ‘‘dicing’’
the Emx2-mRNA/Emx2OS-ncRNA hybrid, similarly to retro-
transposon silencing [47,49]. Consistently with this model, the
concomitant up-regulation of Emx2OS-ncRNA caused by OS1-
179(+) might reflect a reduced degradation rate of the endogenous
antisense molecule, following the competition by OS1-179(+) for
sense transcript binding.
Remarkably, Emx2OS-dependent down-regulation of Emx2 is
not limited to proliferating neural precursors. It takes place also in
differentiating neuronal progenitors, where a surplus of Emx2OS-
ncRNA is available to trigger this process (Fig. 5C, bottom left).
Here, an up-regulation of key enzymes involved in sense RNA
degradation, occurring during neuronal differentiation [66], might
make the Emx2OS impact on Emx2-mRNA degradation predom-
inant over its positive effects on sense transcription, so accelerating
the shutting off of the sense transcript. Actually, the amplitude of
Emx2OS-dependent Emx2 downregulation is apparently not huge.
Notwithstanding that, such regulation might be instrumental to
proper progression of cortico-cerebral morphogenesis. In fact, as
Emx2 finely regulates the balance between symmetric, self-
renewing divisions undergone by embryonic neural stem cells
and asymmetrical, neuronogenic ones [12], an accurate regulation
of its expression levels and, in particular, a finely tuned decay of its
mRNA may be crucial to proper growth of the neocortical
primordium [14]. A moderate contribution of Emx2OS-ncRNA to
Emx2-mRNA destabilization might be just required, for optimal
tuning of this process.
Materials and Methods
Ethics Statement
Animals handling and subsequent procedures were in accor-
dance with European laws [European Communities Council
Directive of November 24, 1986 (86/609/EEC)] and with
National Institutes of Health guidelines.
Animal Handling
Wt mice (strain CD1, purchased from Harlan-Italy) and Emx2
null mutants [4] used in this study are maintained at the SISSA-
CBM mouse facility. Embryos were staged by timed breeding and
vaginal plug inspection. Embryos (E10.5-E18.5) were harvested
from pregnant dames killed by cervical dislocation.
Preparation of Histological Samples
Dissected embryos were immersion-fixed overnight in 4%
paraformaldehyde in 1X phosphate saline buffer (PBS) and then
cryoprotected by immersion in 30% sucrose in PBS 1X overnight
at 4uC. Tissues were frozen in OCT compound, sectioned at
10 mm in a cryostat, collected on slides SuperFrost Plus (Fischer),
air dried for about 30 min, and stored at – 80uC until use.
Cell Cultures
Primary cells. Cortical primordia and rhombo-spinal tracts
were dissected from E12.5 mouse embryos and mechanically
dissociated to single cells, by gentle pipetting. Dissociated neural
precursor cells were cultured at 700 cells/ml, in DMEM/F12/
Glutamax medium (InvitrogenTM), integrated with N2 supplement
(InvitrogenTM), 1 mg/ml BSA, 0.6% w/v glucose, 2 mg/ml
heparin, 10 pg/ml Fgf2, 20 pg/ml Egf, 1X Pen/Strept (Gibco),
10 pg/ml fungizone. Cultures were usually blocked and under-
went RNA extraction 72 hours after dissection. When a longer
culturing time was required, primary neurospheres were
dissociated to single cells by trypsin-DNAseI and re-plated at the
same initial density. When required, doxycycline, lithium chloride
and cyclopamine were added to the culture medium, at 2 mg/ml,
1mM and 1 mM, respectively.
HeLa cells and NIH/3T3 cells. Cells were cultured in
DMEM-Glutamax-ITM (Gibco) plus 10%FBS, according to
standard protocols. When appropriate, a-Dicer (59 GGCTT
TTCAA TCATC CAGTG TTTCT 39) and control (59
TCTTT GTGAC CTACT AACTT TTCGG 39) morpholinos
were delivered to cells at 10 mM, by 6 mM EndoPorterTM carrier
(GeneTools), according to manifacturer’s instructions. When
required, doxycycline was added to the culture medium, at
2 mg/ml.
Immunofluorescence
Neural cells were detached form plates by 1X trypsin (Gibco) for
5 minutes at RT, centrifuged at 100 g for 7 min at RT,
resuspended in Sato medium and finally left 60 min to attach to
SuperfrostH slides, previously kept for 60 min under 20 mg/ml
poly-D-lysine at RT. Immunofluorescence was performed as
previously described [66], with minor modifications. Briefly, after
fixation by 4% paraformaldehyde for 10 min at 4uC and three
washes in 1X PBS, 5 min each, cells were incubated for 1 h at RT
under blocking mix (1X PBS; 10% FBS; 1 mg/ml BSA; 0.1%
Triton-X100) and then incubated at 4uC overnight with primary
antibody in blocking mix. Mouse anti-neuron-specific class III
b-tubulin-primary antibody (clone Tuj1, Covance), was used,
1:600. Immunoreactivity was revealed after a 2 h incubation with
secondary Alexa-594 antibody, 1:600.
In Situ Hybridization
Not radioactive in situ hybridization was performed as
previously described, with minor modifications [67]. Two ribop-
robes were used: Emx2OS, corresponding to mouse chromosome
19: nt 59,500,768-59,501,561, and Reln, corresponding to the
3.3 kb EcoRI fragment from the BS6 clone (a gift by A.Bulfone).
Hybridized embryo sections were imaged and analyzed using a
fluorescent Nikon (Tokyo, Japan) Eclipse 80i microscope and
a DS-2MBWC digital microscope camera. All images were
processed by Adobe Photoshop CS3 software.
Quantitative RT-PCR
RNA preparation. RNA was extracted from CNS explants
and cell cultures by TrizolTM (Invitrogen), according to
manifacturer’s instructions.
cDNA prepration. At least 1 mg of RNA from each sample
was retrotranscribed by SuperScriptIIITM (Invitrogen) in the
presence of random hexamers, according to manifacturer’s
instructions, with minor modifications. In the case of pre-mRNA
levels evaluation, at least 4 mg of RNA preparation from each
sample, previously treated by DNAseITM (Promega), were used.
Quantitative PCR. 1/25 of each cDNA sample was analyzed
by the SybrGreenTM qPCR platform (Biorad). Each PCR reaction
was run at least in triplicate and results averaged. Averages were
further normalized against Tbp, except data in Fig. 5B (left and
middle graphs), conversely normalized against GAPDH.
Specifically in the case of pre-mRNA levels evaluation (reported
in Fig. 5B, right graph), to reconcile sensitivity and specificity, 1/2
of each cDNA sample was linearly pre-amplified and 1/100 of the
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resulting primary reaction product was used as substrate of the
subsequent quantitative PCR reaction, driven by nested, internal
primers. Finally, supplementary amplifications on not-retrotrans-
cribed samples were run, as negative controls.
Oligonucleotides. Genomic localization of oligonucleotides
used in this study are shown in Fig. 1A. Amplicons and corres-
ponding oligos were as follows: Emx2-mRNA (E2S/N2F: 59
GGAAA GGAAG CAGCT GGCTC ACAGT CTCAG TCTTA
C 39; E2S/N2R: 59 GTGGT GTGTC CCTTT TTTCT TC-
TGT TGAGA ATCTG AGCCT TC 39); Emx2OS-ncRNA
(Emx2OS/P1: 59 CCCGC GCCCG GGTCA CTGAG ATGGC
TTCG 39; Emx2OS/P3: 59 GATGA GCAGG TGAGT GGTAG
ATGGT TGTAA GCTGT AC 39); Emx2-pre-mRNA-primary
PCR (I1: 59 GTCTC TGAAG CTCGT TTGGG TTACT G 39;
I4: 59 AGTGA GTGTA GAGCA GAGTT GAAGT CC 39);
Emx2-pre-mRNA-secondary PCR (I2: 59 GCGAG GTCTT
TGAAT CCTGT TTC 39; I3: 59 GCAGA GTTGA AGTCC
AGTGA ACC 39); Tbp-mRNA (Tbp-b/Fw: 59 ATTCT CAAAC
TCTGA CCACT GCACC GTTG 39; Tbp-b/Rev: 59 TTAGG
TCAAG TTTAC AGCCA AGATT CACGG TAG 39); Gapdh-
mRNA (Gapd/FW: 59 CAACA GCAAC TCCCA CTCTT
CCACC TTCG 39; Gapd/REV: 59 GGTGG TCCAG GGTTT
CTTAC TCCTT GGAGG 39); Tbp-pre-mRNA-primary PCR
(TBP-FW/EXT: 59 CTCAG TTTGA TGGCT CAGTT TCC
39; TBP-REV/EXT: 59 GTATA ACCAG TTATT TATCC
AGATC TC 39); Tbp-pre-mRNA- secondary PCR (TBP-FW/
INT: 59 CAAAA GATGA AAACC CAGAA AACAG CC 39;
TBP-REV/INT: 59 GTTTA CTGAA CGCTT GATTA TA-
TAG 39).
Plasmids Construction
All basic DNA manipulations (extraction, purification, ligation)
as well as bacterial cultures and transformation, media and buffer
preparations were performed according to standard methods.
DNAs were transformed in the E.Coli TOP-10 strains (Invitro-
gen).
Loss-of-Function Constructs and Their Validation
To knock-down Emx2OS by RNAi, we selected the best two
siRNAs suggested by the Invitrogen ‘‘BLOCK-iTTM RNAi
Designer‘‘ software (miR-aEmx2OS-542 and miR-aEmx2OS-774)
plus the BLOCK-iTTM negative control-miR (miR-C) and
compared their activities on Hela cells. For this purpose, we built
up a set of three bicistronic plasmids, each harboring two distinct
transcription units and designed to assay the activity of one specific
miR. The former transcription unit, the ‘‘sensor’’, included the
CMV promoter, the DsRed2 coding sequence, the cDNA
corresponding to the Emx2OS-ncRNA fragment targeted in silico
by the two miRs above (Genbank AY117414.1: nt796-1289) and
the SV40 polyA site. The latter unit, the ‘‘miR expressor’’,
harbored the CMV promoter, the eGFP coding sequence, a
modified 230bp fragment from pri-mmu-miR-155 (where the
miR-155 and miR-155* moieties are replaced by those of the
artificial miR in order) and the TK polyA site. A fourth plasmid
was built up as well, similar to the previous three, but harboring in
cis sequences encoding for both miR-aEmx2OS-542 and miR-
aEmx2OS-774 (Fig.1B). The pri-miR fragments included in the
above mentioned plasmids were prepared as follows. Each of the
two sequences 59 TGCTG CATAT TTGCA CTTCT CCGAA
GGTTT TGGCC ACTGA CTGAC CTTCG GAGGT GCAAA
TATGC AGG 39 and 59 TGCTG CGAAC TTAGA CTCAG
ATTCC CGTTT TGGCC ACTGA CTGAC GGGAA TCTGT
CTAAG TTCGC AGG 39 was cloned into pcDNATM6.2-GW/
EmGFP-miR (Invitrogen), inbetween mmu-miR-155 flanking
regions, according to manifacturer’s instructions, and the resulting
SalI-XhoI chimeric pri-miR cDNA fragments, encoding for miR-
aEmx2OS-542 and miR-aEmx2OS-774, respectively, were ob-
tained. Finally, the SalI-XhoI cDNA fragment from ‘‘pcDNATM
6.2-GW/EmGFP-miR_neg_control_ plasmid’’ was used as control
pri-miR.
We transfected HeLa cells with these four bicistronic plasmids,
counted fluorescent cells and calculated for each plasmid the ratio
between red cells and total fluorescent cells, as a comprehensive
index of pri-miR processing efficiency and mature miR activity.
The DsRed2+/(total fluorescent cells) ratio varied from 65%
(negative control miR), to 39% (miR-aEmx2OS-542), 10% (miR-
aEmx2OS-774) and 2% (miR-aEmx2OS-542 & miR-aEmx2OS-
774), suggesting that the combination in cis of the two miRs, -542
and -774, would be the best choice (Fig. 5A). However, we noticed
that, using the -542/-774 plasmid, the ratio between eGFP+ cells
and total cells in the plate was consistently lower (data not shown),
possibly because of enhanced Drosha-dependent destabilization of
the chimaeric eGFP-cds/Pri-miR molecule. As this might pose
serious problems in subsequent production of miR-encoding
lentiviruses as well as in tracing cells infected by these virions,
we prudently opted for simple miR-aEmx2OS-774 for the
knocking-down experiments.
Finally, the pri-miR-aEmx2OS-774 and ‘‘control pri-miR’’
SalI/XhoI cDNA fragments were transferred into the SalI-
digested, pCCLsin.PPT.hPGK.GFP.pre plasmid [68], inbetween
the pPgk1/GFP and Wpre modules, so obtaining the genomic
plasmids used for subsequent production of miR-expressor
lentiviruses (Fig. 1B).
Conditional Gain-of-Function Constructs
Emx2OS/Emx2 RNA sequences were conditionally overex-
pressed by lentiviral vectors and TetON technology.
The ‘‘driver lentivector’’ encoded for a constitutively expressed
rtTA transactivator. Its genomic plasmid was obtained by replacing
the BamHI/SalI eGFP cassette of pCCLsin.PPT.hPGK.GFP.pre
by a BamHI/XhoI rtTA2S-M2 module.
‘‘Expressor viruses’’ encoded for a doxycycline-controlled
chimaeric transgene, including the cDNA fragment subject of
analysis plus an IRES/eGFP module. Its genomic plasmid was
obtained starting from pCCLsin.PPT.hPGK.GFP.pre, replacing
the pPgk1 promoter by an ‘‘tTA/rtTA responsive element, tight’’
(TREt), the eGFP cds by an IRES/eGFP module and finally
cloning the cDNA in order inbetween TREt and IRES/eGFP. Two
‘‘expressor viruses’’ were built up: the former harbored the cDNA
fragment corresponding to nucleotides 1–179 of Emx2OS-ncRNA
[OS1-179(+)], the latter the reverse-complementary sequence
[OS1-179(2)]. A third virus, not including any Emx2 sense or
antisense sequences was used as a negative control (Fig. 1C).
Morpholino Reagents and Their Validation
Sequences of anti-Dicer1 morpholino and its reverse negative
control were obtained from the Gene-Tools free design service (a-
Dicer1 and C, respectively) and the former molecule was
validated, by testing its capability to inhibit Dicer1-dependent
pri-miR-124a maturation [56]. This was assayed by a DsRed2
sensor gene linked to a miR-124a responsive element, co-
trasfected into NIH/3T3 cells with pri-miR-expressor plasmids
(Fig. S1).
Lentiviruses Preparation, Titration and Usage
Lentiviruses were prepared and titrated as previously described
[68–70], with minor modifications.
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Cell infections were performed without polybrene. In gain-of-
function experiments, each virus was used at ‘‘multiplicity of
infection’’ (m.o.i.) = 10, which resulted in trasduction of almost the
totality of cortical precursors [71]. The m.o.i. was raised to 20 in
loss-of-function experiments, in order to get a more robust
downregulation of the target RNA.
Statistical Analysis
All experiments were performed at least in biological triplicate.
Tbp- (or GAPDH-) normalized qRT-PCR data relative to each
treatment were further averaged and the corresponding s.e.m.’s ae
determined. Resulting averages were finally normalized against
the control treatment, as reported in Figure Legends. Statistical
significance of differences among results was evaluated by one- or
two-ways ANOVA.
Supporting Information
Figure S1 Validation of a-Dicer1 morpholino in NIH/3T3
cells. (A) Rationale of the assay: a-Dicer1-dependent suppression
of pri-miR-124a-dependent DsRed2 inhibition. (B) Molecular
tools for validating a-Dicer1 activity: inserts of pri-miR-expressor
and miR-124a-sensor plasmids; sequences of a-Dicer1 and control
morpholinos. The miR-124a responsive element (miR-124a-RE)
corresponds to the 477-bp 39UTR fragment of mouse Lhx2-
mRNA (chr2 (+):38224759-38225235); Pri-miR-124a corresponds
to the 285-bp mouse Pri-miR-124(2) genomic fragment (chr3
(+):17695562-17695846); control Pri-miR contains the Pri-
miR155 sequence from the BLOCK-iTTM expression vector
(Invitrogen). (C) Rescue of miR124a-dependent DsRed2 inhibition
by a-Dicer1 morpholino, in NIH/3T3 cells.
Found at: doi:10.1371/journal.pone.0008658.s001 (8.78 MB TIF)
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